Zhejiang Medicine Co Ltd banner

Zhejiang Medicine Co Ltd
SSE:600216

Watchlist Manager
Zhejiang Medicine Co Ltd Logo
Zhejiang Medicine Co Ltd
SSE:600216
Watchlist
Price: 16.77 CNY -1.64% Market Closed
Market Cap: ¥16.1B

Profitability Summary

Zhejiang Medicine Co Ltd's profitability score is 52/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

52/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

52/100
Profitability
Score
52/100
Profitability
Score

Margins

Earnings Waterfall
Zhejiang Medicine Co Ltd

Margins Comparison
Zhejiang Medicine Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Zhejiang Medicine Co Ltd
SSE:600216
16.1B CNY
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
951.3B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
595.7B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
289.1B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
246.1B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
234.1B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
297.5B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151.6B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
124.5B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Zhejiang Medicine Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Zhejiang Medicine Co Ltd
SSE:600216
16.1B CNY
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
951.3B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
595.7B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
289.1B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
246.1B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
234.1B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
297.5B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151.6B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
124.5B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Zhejiang Medicine Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett